A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Cancer and Aging Research Program Bookmark and Share

Cancer and Aging Research Program

The number of older patients with cancer and surviving cancer is rapidly growing because the U.S. population is aging with a projected doubling in the number of patients 65 and older by 2030. Although the majority of cancers occur in older adults, these patients have been under-represented in national cancer clinical trials, which set the standards for oncology care. Few studies have specifically focused on the unique issues which face older adults such as the impact of age related declines in physiology, polypharmacy or comorbid medical conditions on treatment tolerance.
 
Arti Hurria, M.D. leads City of Hope's Cancer and Aging Research Program, the mission of which is to join investigators from all cancer disciplines to study biology, treatment and survivorship issues that face older adults with cancer. The results of this research will be applicable to the majority of patients with cancer because approximately 60 percent of cancer diagnoses and 70 percent of cancer mortality occur in patients over the age of 65.
 
In addition, Hurria established the Cancer and Aging Research Group in order to further research in geriatric oncology. This group is comprised of physicians and researchers across the country who collaborate in many different clinical trials benefiting older adults.
 
Cancer and Aging Research Group (CARG) at mycarg.org: http://www.mycarg.org/
 

Research Focus

  • Research Focus
     
  • Role of Geriatric Assessment in the care of the older patient with cancer (understanding an individual’s physiologic age verses chronological age) 
     
  • Adjuvant treatment decisions in older patients with breast cancer
     
  • Cognitive effects of cancer therapy in older cancer patients
     
  • Pharmacokinetics of cancer therapy with aging
 

Science to Meet a Critical Need

City of Hope is home to one of the few specialized research programs designed to meet the unique needs of older adults with cancer. This is a crucial area of study that will only grow in the coming years.
  • Between 2010 and 2030, cancer incidence is expected to rise 67 percent in those age 65 or older, compared to 11 percent for those under age 65.
  • Approximately 60 percent of all cancers occur in people aged 65 years or older.
  • Older adults with cancer are underrepresented in the clinical trials that shape national standards for cancer care.

Older Adults are Unique

Not all 70-year-olds are alike. Chronological age does not tell the whole story. The team of Arti Hurria, M.D., has developed a comprehensive assessment to determine the functional age of older adults, therefore enabling a more tailored approach to cancer care.
  • Utilizing the information gathered during the assessment, a score can be determined to predict which older adults will be at increased risk for chemotherapy side effects. Knowing which patients may suffer an increased risk of side effects could influence treatment decisions made by doctors and patients.
  • Older adults typically have other medical conditions that need to be considered when choosing the type of therapy.
  • Older adults often take several prescribed medications. A careful medication review needs to be performed in order to understand which can interact with cancer treatment.
  • Older adults may have different preferences regarding treatments, taking into account the side effects of various treatment options and the impact of therapy on their ability to live independently.


Older Adults

Innovation and Research

The research of Arti Hurria, M.D., has led to the development of a chemotherapy toxicity calculator, a prechemotherapy assessment that captures information which can be used to predict which older adults are the most vulnerable to serious side effects from cancer treatment. Ultimately, the chemotherapy toxicity calculator will be used in clinical practice, where it will be a part of shared decision-making between the health care provider, patient and the patient’s family. It is also being developed into a mobile app for future use.

Additionally:
  • Two clinical trials of novel cancer treatments are being conducted in older adults.
  • Research studies to determine the effects of chemotherapy on memory.
  • Research to support caregivers: the impact of a loved one’s cancer care and ways to provide support.

Collaboration

Arti Hurria, M.D., founded and leads the Cancer and Aging Research Group, which joins investigators across the nation in collaborative research to design and implement clinical trials to improve the care of older adults with cancer. More information can be found at www.mycarg.org

How You Can Help

Donate today to provide hope for older adults with cancer through innovative research.

Research is the only way forward against cancer in older adults. And progress is only possible with the help of generous donors.

Your gift makes a difference. Join forces with Arti Hurria, M.D., and her team and help transform the future of health for older adults with cancer.

You can also create a personal fundraising page. Share your story and inspire friends, family and associates to support this lifesaving mission. Please visit https://ourhope.cityofhope.org/events/dr-hurria-fundraising-page/e43974.

To learn more, contact Janet Morgan, Senior Development Officer at jmorgan@coh.org.

City of Hope Philanthropy
1500 East Duarte Road, Duarte, CA 91010
800-667-5310
philanthropy@coh.org
 

About Dr. Arti Hurria

Arti Hurria, M.D.
Arti Hurria, M.D.
Associate Professor of Medical Oncology
Director, Cancer and Aging
Research Program


An award-winning investigator, Arti Hurria, M.D., is an internationally recognized expert in geriatric oncology. Through her studies, her leadership, her advocacy and her mentorship of up-and-coming researchers, she promotes longer, healthier lives for older adults everywhere.

Staff

Bihong (Beth) Chen, M.D., Ph.D.

Bihong (Beth) Chen, M.D., Ph.D.
Title: Associate Clinical Professor
Contact Info: bechen@coh.org
 
  Yuan Yuan, M.D., Ph.D.

Yuan Yuan, M.D., Ph.D.
Title: Assistant Professor
Contact Info: yuyuan@coh.org
 
Peggy S. Burhenn, M.S., C.N.S., A.O.C.N.S.

Peggy S. Burhenn, M.S., C.N.S., A.O.C.N.S.
Title: Professional Practice Leader
Contact Info: pburhenn@coh.org
 
  Ellen Liu, R.N., M.S., FNP-C

Ellen Liu, M.S.
Title: Nurse Practitioner (R.N., M.S., FNP-C)
Contact Info: eliu@coh.org
 
Daisy Rivera, L.C.S.W.

Daisy Rivera, L.C.S.W.
Title: Social Worker III
Contact Info: drivera@coh.org
 
  David D. Smith, Ph.D.

David D. Smith, Ph.D.
Title: Research Professor
Contact Info: dsmith02@coh.org
 
Vani Katheria, M.S.

Vani Katheria, M.S.
Title: Cancer and Aging Program Manager
Contact Info: vkatheria@coh.org
 
  Chie Akiba

Chie Akiba
Title: Clinical Research Associate II
Contact Info: cakiba@coh.org
 
Jennifer Choi

Jennifer Choi
Title: Clinical Research Assistant I
Contact Info: jechoi@coh.org
 
  Anait Arsenyan

Anait Arsenyan
Title: Clinical Research Associate II
Contact Info: aarsenyan@coh.org
 
Abrahm Levi

Abrahm Levi
Title: Clinical Research Assistant I
Contact Info: alevi@coh.org
 
  Julie Filo

Julie Filo
Title: Clinical Research Assistant I
Contact Info: jfilo@coh.org
 
Andrea Rubalcava

Andrea Rubalcava
Title: Clinical Research Assistant I
Contact Info: anrubalcava@coh.org
 
  Dawnyetta Reese

Dawnyetta Reese
Title: Senior Administrative Support
Contact Info: dreese@coh.org
 
Judith Bishop

Judith Bishop
Title: Business Manager
Contact Info: jubishop@coh.org
 
  Dale Mitani

Dale Mitani
Title: Application Developer
Contact Info: dmitani@coh.org
 
 

Cancer and Aging Research Program

Cancer and Aging Research Program

The number of older patients with cancer and surviving cancer is rapidly growing because the U.S. population is aging with a projected doubling in the number of patients 65 and older by 2030. Although the majority of cancers occur in older adults, these patients have been under-represented in national cancer clinical trials, which set the standards for oncology care. Few studies have specifically focused on the unique issues which face older adults such as the impact of age related declines in physiology, polypharmacy or comorbid medical conditions on treatment tolerance.
 
Arti Hurria, M.D. leads City of Hope's Cancer and Aging Research Program, the mission of which is to join investigators from all cancer disciplines to study biology, treatment and survivorship issues that face older adults with cancer. The results of this research will be applicable to the majority of patients with cancer because approximately 60 percent of cancer diagnoses and 70 percent of cancer mortality occur in patients over the age of 65.
 
In addition, Hurria established the Cancer and Aging Research Group in order to further research in geriatric oncology. This group is comprised of physicians and researchers across the country who collaborate in many different clinical trials benefiting older adults.
 
Cancer and Aging Research Group (CARG) at mycarg.org: http://www.mycarg.org/
 

Research Focus

Research Focus

  • Research Focus
     
  • Role of Geriatric Assessment in the care of the older patient with cancer (understanding an individual’s physiologic age verses chronological age) 
     
  • Adjuvant treatment decisions in older patients with breast cancer
     
  • Cognitive effects of cancer therapy in older cancer patients
     
  • Pharmacokinetics of cancer therapy with aging
 

Science to Meet a Critical Need

Science to Meet a Critical Need

City of Hope is home to one of the few specialized research programs designed to meet the unique needs of older adults with cancer. This is a crucial area of study that will only grow in the coming years.
  • Between 2010 and 2030, cancer incidence is expected to rise 67 percent in those age 65 or older, compared to 11 percent for those under age 65.
  • Approximately 60 percent of all cancers occur in people aged 65 years or older.
  • Older adults with cancer are underrepresented in the clinical trials that shape national standards for cancer care.

Older Adults are Unique

Older Adults are Unique

Not all 70-year-olds are alike. Chronological age does not tell the whole story. The team of Arti Hurria, M.D., has developed a comprehensive assessment to determine the functional age of older adults, therefore enabling a more tailored approach to cancer care.
  • Utilizing the information gathered during the assessment, a score can be determined to predict which older adults will be at increased risk for chemotherapy side effects. Knowing which patients may suffer an increased risk of side effects could influence treatment decisions made by doctors and patients.
  • Older adults typically have other medical conditions that need to be considered when choosing the type of therapy.
  • Older adults often take several prescribed medications. A careful medication review needs to be performed in order to understand which can interact with cancer treatment.
  • Older adults may have different preferences regarding treatments, taking into account the side effects of various treatment options and the impact of therapy on their ability to live independently.


Older Adults

Innovation and Research

Innovation and Research

The research of Arti Hurria, M.D., has led to the development of a chemotherapy toxicity calculator, a prechemotherapy assessment that captures information which can be used to predict which older adults are the most vulnerable to serious side effects from cancer treatment. Ultimately, the chemotherapy toxicity calculator will be used in clinical practice, where it will be a part of shared decision-making between the health care provider, patient and the patient’s family. It is also being developed into a mobile app for future use.

Additionally:
  • Two clinical trials of novel cancer treatments are being conducted in older adults.
  • Research studies to determine the effects of chemotherapy on memory.
  • Research to support caregivers: the impact of a loved one’s cancer care and ways to provide support.

Collaboration

Collaboration

Arti Hurria, M.D., founded and leads the Cancer and Aging Research Group, which joins investigators across the nation in collaborative research to design and implement clinical trials to improve the care of older adults with cancer. More information can be found at www.mycarg.org

Clinical Trials

How You Can Help

How You Can Help

Donate today to provide hope for older adults with cancer through innovative research.

Research is the only way forward against cancer in older adults. And progress is only possible with the help of generous donors.

Your gift makes a difference. Join forces with Arti Hurria, M.D., and her team and help transform the future of health for older adults with cancer.

You can also create a personal fundraising page. Share your story and inspire friends, family and associates to support this lifesaving mission. Please visit https://ourhope.cityofhope.org/events/dr-hurria-fundraising-page/e43974.

To learn more, contact Janet Morgan, Senior Development Officer at jmorgan@coh.org.

City of Hope Philanthropy
1500 East Duarte Road, Duarte, CA 91010
800-667-5310
philanthropy@coh.org
 

About Dr. Arti Hurria

About Dr. Arti Hurria

Arti Hurria, M.D.
Arti Hurria, M.D.
Associate Professor of Medical Oncology
Director, Cancer and Aging
Research Program


An award-winning investigator, Arti Hurria, M.D., is an internationally recognized expert in geriatric oncology. Through her studies, her leadership, her advocacy and her mentorship of up-and-coming researchers, she promotes longer, healthier lives for older adults everywhere.

Staff

Staff

Bihong (Beth) Chen, M.D., Ph.D.

Bihong (Beth) Chen, M.D., Ph.D.
Title: Associate Clinical Professor
Contact Info: bechen@coh.org
 
  Yuan Yuan, M.D., Ph.D.

Yuan Yuan, M.D., Ph.D.
Title: Assistant Professor
Contact Info: yuyuan@coh.org
 
Peggy S. Burhenn, M.S., C.N.S., A.O.C.N.S.

Peggy S. Burhenn, M.S., C.N.S., A.O.C.N.S.
Title: Professional Practice Leader
Contact Info: pburhenn@coh.org
 
  Ellen Liu, R.N., M.S., FNP-C

Ellen Liu, M.S.
Title: Nurse Practitioner (R.N., M.S., FNP-C)
Contact Info: eliu@coh.org
 
Daisy Rivera, L.C.S.W.

Daisy Rivera, L.C.S.W.
Title: Social Worker III
Contact Info: drivera@coh.org
 
  David D. Smith, Ph.D.

David D. Smith, Ph.D.
Title: Research Professor
Contact Info: dsmith02@coh.org
 
Vani Katheria, M.S.

Vani Katheria, M.S.
Title: Cancer and Aging Program Manager
Contact Info: vkatheria@coh.org
 
  Chie Akiba

Chie Akiba
Title: Clinical Research Associate II
Contact Info: cakiba@coh.org
 
Jennifer Choi

Jennifer Choi
Title: Clinical Research Assistant I
Contact Info: jechoi@coh.org
 
  Anait Arsenyan

Anait Arsenyan
Title: Clinical Research Associate II
Contact Info: aarsenyan@coh.org
 
Abrahm Levi

Abrahm Levi
Title: Clinical Research Assistant I
Contact Info: alevi@coh.org
 
  Julie Filo

Julie Filo
Title: Clinical Research Assistant I
Contact Info: jfilo@coh.org
 
Andrea Rubalcava

Andrea Rubalcava
Title: Clinical Research Assistant I
Contact Info: anrubalcava@coh.org
 
  Dawnyetta Reese

Dawnyetta Reese
Title: Senior Administrative Support
Contact Info: dreese@coh.org
 
Judith Bishop

Judith Bishop
Title: Business Manager
Contact Info: jubishop@coh.org
 
  Dale Mitani

Dale Mitani
Title: Application Developer
Contact Info: dmitani@coh.org
 
 


NEWS & UPDATES
  • The physical side effects of cancer can damage anyone’s self-confidence, but especially that of women who, rightly or wrongly, are more likely to find their appearance (or their own perception of their appearance) directly connected to their ability to face the world with something resembling ap...
  • The promise of stem cell therapy has long been studied in laboratories. Now, as medicine enters an era in which this therapy will be increasingly available to patients, the nurses who help deliver it will be in the spotlight. City of Hope, which has launched its Alpha Clinic for Cell Therapy and Innovation (ACT...
  • Just because you can treat a condition, such as high cholesterol, at the end of life — well, that doesn’t mean you should. That’s the basic lesson of a study to be published March 30 in JAMA Internal Medicine. The ramifications go far beyond that. The research, in which City of Hope’s Betty Fe...
  • The understanding of the relationship between genetics and cancer risk continues to grow, with more genetic testing than ever before available to patients. However, the adage that a little knowledge is a dangerous thing is applicable: Without context for what a test result means, and without meaningful guidance...
  • Standard prostate biopsies haven’t changed significantly in the past 30 years – nor have the problems inherent with them. Regular biopsies have an expected error rate: Tumors may potentially be undersampled and, 30 percent of the time, men who undergo a radical prostatectomy are found to have more aggress...
  • In the field of cancer, patients have had surgery, chemotherapy and radiation therapy as options. Now, as City of Hope officially opens the Alpha Clinic for Cellular Therapy and Innovation, patients battling cancer and other life-threatening diseases have another option: stem-cell-based therapy. The Alpha Clini...
  • How does the environment affect our health? Specifically, how does it affect our risk of cancer? City of Hope physicians and researchers recently answered those questions in an Ask the Experts event in Corona, California, explaining the underlying facts about how the environment can affect our health. Moderator...
  • Nurses and other medical professionals have come to understand that it’s not enough just to fight disease. They also must provide pain relief, symptom control, and an unrelenting commitment to improve patients’ quality of life — especially at the end of life. Not too long ago, this was a relatively ...
  • “Tonight, I’m launching a new precision medicine initiative to bring us closer to curing diseases like cancer.” These were the words of President Barack Obama on Jan. 20, 2015, during his State of the Union address. So what is precision medicine, and how close are we to making it a reality for...
  • March is Colon Cancer Awareness Month. How sad, yet how serendipitous, that the co-creator of “The Simpsons” Sam Simon passed away in March after a four-year battle against colon cancer. What message can we all learn from his illness that can help us prevent and overcome colon cancer in our own lives? Colon can...
  • Misagh Karimi, M.D., assistant clinical professor, is a medical oncologist at one of City of Hope’s newest community practice locations, located in Corona in Riverside County. A recent community health report from Corona’s public health department stated that obesity rates for teens and adults in Riverside Coun...
  • In 1975, the median survival for patients with ovarian cancer was about 12 months. Today, the median survival is more than 5 years. Although researchers and clinicians are far from satisfied, the progress in ovarian cancer treatment is encouraging, said Robert Morgan, M.D., F.A.C.P., professor of medical oncolo...
  • Colorectal cancer may be one of the most common cancers in both men and women, but it’s also one of the most curable cancers. Today, because of effective screening tests and more advanced treatment options, there are more than 1 million survivors of colorectal cancer in the United States. Here, colorectal...
  • Breast cancer treatment can damage a woman’s ability to become pregnant, making the impact on fertility one of the key factors that many consider when choosing a therapy regimen. Now a study has found that breast cancer patients treated with a hormone-blocking drug in addition to chemotherapy were less li...
  • My colleagues in the clinic know I’ve got a soft spot. Last week, a patient of mine offered me a fantastic compliment. “You’re looking younger these days, Dr. Pal!” she said, offering me a big hug as she proceeded out of the clinic room. Lovely, I thought. The early morning workouts are paying off. She continue...